Seeking Alpha

BioMarin Pharmaceuticals (BMRN -1.8%) slips on a downgrade to Hold at Deutsche. The firm says...

BioMarin Pharmaceuticals (BMRN -1.8%) slips on a downgrade to Hold at Deutsche. The firm says much of the good news is baked into the stock, and it sees no compelling risk/reward tradeoff going all the way into Q4.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|